Search for: "Watson Pharmaceuticals" Results 21 - 40 of 360
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Mar 2018, 3:28 am by Jane Meacham, Contributing Editor
Some pharmaceutical companies also still sponsor traditional pensions for most salaried new hires. [read post]
21 Mar 2018, 3:28 am by Jane Meacham, Contributing Editor
Some pharmaceutical companies also still sponsor traditional pensions for most salaried new hires. [read post]
7 Dec 2017, 9:34 pm by Patent Docs
Seeking approval to market generic versions of Eli Lilly's Axiron® testosterone applicator, Defendants Perrigo Company and Perrigo Israel Pharmaceuticals Ltd., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc. and Lupin Ltd., and Amneal Pharmaceuticals LLC filed... [read post]
5 Dec 2017, 12:29 pm by Overhauser Law Offices, LLC
., and Acrux DDS Pty Ltd. had filed a patent infringement lawsuit in the Southern District of Indiana alleging that Defendants, Perrigo Company, Perrigo Israel Pharmaceuticals Ltd., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc., and Lupin LTD infringed patent no. 8,435,944, Method and Composition for Transdermal Drug Delivery (the ‘944 patent) and 8,807,861, Spreading Implement, (the ‘861 patent), which have been… [read post]
8 Nov 2017, 7:26 am by CJ Haddick
Paul Insurance companies owe no duty to defend or indemnify Watson Pharmaceutical in governmental suits against the pharmaceutical company over the deceptive marketing of opioids. [read post]
12 Jun 2017, 3:00 am
Partially an advertisement for IBM’s Watson data analytics and insight services (“cognitive engine”), the presentation gave a taste of things to come for pharmaceutical companies and their advisers. [read post]
2 Jun 2017, 3:06 am by Walter Olson
Thomas Watson, Robert H. [read post]
27 Apr 2017, 1:30 am by Thaddeus Mason Pope, JD, PhD
Come prepared for a lively, interactive workshop.World Café Hosts:Dayna Matthew, University of Colorado Law SchoolCharity Scott, Georgia State University College of LawSidney Watson, Saint Louis University School of LawInvited Discussants and Participants:Rodney Adams, Virginia Commonwealth University School of Health AdministrationChristina Juris Bennett, University of Oklahoma College of LawAmy Campbell, University of Memphis Cecil C. [read post]
5 Apr 2017, 9:08 am by Lawrence B. Ebert
With respectto Watson, the PTAB found that it “does not controlhere because [Appellee] Noven [Pharmaceuticals Inc. [read post]
14 Feb 2017, 9:13 pm by Patent Docs
The lawsuit involved Watson's ANDA filing seeking approval for a generic version of Shire's controlled-release oral pharmaceutical composition for the treatment of inflammatory bowel disease, Crohn's disease, and ulcerative colitis, sold by Shire under the brand name LIALDA®. [read post]
8 Feb 2017, 3:09 am by Dennis Crouch
Watson Laboratories, Inc., No. 16-493 (pre-AIA, do secret sales count as prior art?) [read post]
23 Jan 2017, 1:25 am by INFORRM
The CJEU’s recent decision in the Tele2/Watson case may call the viability of the new Investigatory Powers Act into question. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Watson Laboratories, Inc., No. 16-493 (pre-AIA, do secret sales count as prior art?) [read post]
15 Jun 2016, 8:08 am by Mark Astarita
  Valvani then traded in advance of public announcements concerning FDA approvals for such companies as Momenta Pharmaceuticals, Watson Pharmaceuticals, and Amphastar Pharmaceuticals. [read post]